本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Teladoc Health Inc.

8.29
-0.0600-0.72%
盤後8.23-0.0600-0.72%16:58 EDT
成交量:388.17萬
成交額:3,209.83萬
市值:14.54億
市盈率:-1.41
高:8.39
開:8.35
低:8.14
收:8.35
資料載入中...
2023/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/04

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/02

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/26

重要事件披露

8-K - Current report
2023/04/17

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/17

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/03

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/03

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/02

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/02

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/01

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/22

重要事件披露

8-K - Current report
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals